Deutsche Bank set a €140.00 ($162.79) target price on Carl Zeiss Meditec (ETR:AFX) in a report published on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
AFX has been the topic of a number of other research reports. Nord/LB set a €132.00 ($153.49) price objective on Carl Zeiss Meditec and gave the stock a buy rating in a research note on Wednesday, December 11th. DZ Bank reissued a neutral rating on shares of Carl Zeiss Meditec in a research note on Tuesday, December 10th. HSBC set a €109.00 ($126.74) price objective on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Tuesday, December 10th. Berenberg Bank set a €114.00 ($132.56) target price on Carl Zeiss Meditec and gave the company a neutral rating in a research report on Thursday, January 23rd. Finally, Independent Research set a €93.00 ($108.14) target price on Carl Zeiss Meditec and gave the company a sell rating in a research report on Tuesday, December 10th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of Hold and an average target price of €111.14 ($129.24).
Shares of ETR:AFX opened at €109.50 ($127.33) on Tuesday. The company has a debt-to-equity ratio of 4.06, a current ratio of 3.84 and a quick ratio of 3.01. The business’s 50 day moving average price is €115.95 and its 200-day moving average price is €106.71. The firm has a market capitalization of $9.79 billion and a PE ratio of 61.31. Carl Zeiss Meditec has a 1 year low of €71.25 ($82.85) and a 1 year high of €122.10 ($141.98).
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
See Also: Inverted Yield Curve
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.